Podcasts about ce podcast

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/the-evolving-role-of-antibody-drug-conjugates-in-metastatic-triple-negative-breast-cancer-10800SummaryThis CME/CE-certified podcast will provide multidisciplinary clinicians with an evidence-based update on the evolving role of TROP2-directed antibody-drug conjugates (ADCs) in the frontline treatment of metastatic triple-negative breast cancer. A medical and an ocular oncology specialist review the latest efficacy and safety data from pivotal clinical trials evaluating ADCs, their integration into contemporary treatment algorithms, and guideline recommendations based on PD-L1 status, BRCA mutation status, and immunotherapy eligibility. Learners will explore key factors influencing treatment selection, compare the benefits and limitations of more established therapeutic options, and examine practical strategies for preventing, recognizing, and managing ADC-associated toxicities. Special emphasis will be placed on multidisciplinary approaches to the management of ocular adverse events and other clinically significant toxicities to optimize patient outcomes and support safe implementation of these therapies in clinical practice.Learning ObjectivesEvaluate the current and emerging clinical evidence surrounding the use of trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugates (ADCs) in the first-line treatment of metastatic triple-negative breast cancer (TNBC)Integrate TROP2-directed ADCs into frontline treatment regimens for metastatic TNBC based on the latest clinical evidence, guidelines, and patient- and tumor-specific factorsApply multidisciplinary and patient-centric strategies for the prevention, recognition, and management of toxicities associated with the use of TROP2-directed ADCs in patients with metastatic TNBCThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology). For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Faculty and Moderator Aditya Bardia, MDProgram Director, Breast Medical Oncology, UCLAProfessor of Medicine, UCLALos Angeles, CADr. Bardia has disclosed the following financial relationships:Consultant: Alyssum, AstraZeneca/Daiichi, BMS, Eli Lilly, Genentech, Gilead, Menarini, Merck, Novartis, Pfizer, VyomeAdvisor/Advisory Board: Alyssum, AstraZeneca/Daiichi, Eli Lilly, Genentech, Gilead, Menarini, Merck, Novartis, Pfizer, VyomeContracted Research: AstraZeneca/Daiichi, Eli Lilly, Genentech, Gilead, Menarini, Merck, Novartis, PfizerStock options: Vyome (immuno-inflammatory and rare diseases)All of his consultant, advisor/advisory board, and contracted research disclosures are related to cancer.Maura Di Nicola, MDAssistant Professor of OphthalmologyBascom Palmer Eye InstituteMedical Director of Imaging and EchographyBascom Palmer Eye InstituteMiami, FLDr. Di Nicola has disclosed the following financial relationships:Consultant: AbbVie (ophthalmology), SpringWorks Therapeutics (oncology)Advisor/Advisory Board: AbbVie (ophthalmology)Research Grant: Castle Biosciences (ocular oncology)Please review additional planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by a medical education grant from AstraZeneca Pharmaceuticals and a medical education grant from Daiichi Sankyo, Inc.Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Tu étudies l'espagnol depuis 1, 2 ou 3 ans, mais tu ne sais pas si tu es encore A2 ou déjà B1 ?Dans cet épisode, je te pose 3 questions concrètes pour évaluer ton niveau d'espagnol et comprendre ce qui te sépare encore du niveau intermédiaire.Challenge: Réveille ton espagnol (du 22 au 26 juin 26). 100% offert, en ligne, avec replay.✅ La NEWSLETTER (pour recevoir toutes les infos sur le challenge):https://www.sicomprendo.net/newsletter/✅​ (COURS D'ESPAGNOL EN LIGNE)Les programmes pour apprendre l'espagnol avec moi: https://www.sicomprendo.net/offres/✅ (MON LIVRE DE VOCABULAIRE): https://www.deboecksuperieur.com/livre/9782807364714-vocabulaire-espagnol-a1-a2-en-1000-mots-200-cartes-mentales-et-en-audio-avec✅​ (COMPTE INSTAGRAM): / paloma.sicomprendo✅​ (PAGE FACEBOOK): https://www.facebook.com/profile.php?...Ce Podcast pour Apprendre l'Espagnol s'adresse aux Débutants et Faux-débutants Francophones qui veulent Apprendre à Parler Espagnol avec une Méthode Immersive et Naturelle pour un projet d'Expatriation, pour prendre la Retraite en Espagne, Communiquer avec leur famille ou tout simplement pour le Plaisir d'Apprendre une nouvelle langue.Auteur - Compositeur de la musique du podcast: Guy Berrier

Dans cet épisode, Jérémie et Simon partagent leur approche à travers le Poids de la Nuance et les raisons pour lesquelles tu devrais l'écouter ! Partages-tu leur avis ?

Comment apprendre une langue quand on a une vie déjà bien remplie ? Peut-on encore progresser efficacement après 30 ou 40 ans ? Quelle différence entre apprendre par obligation et apprendre par passion ?Au fil de la conversation, Gwenaelle explique comment la motivation et l'envie ont transformé sa manière d'apprendre.Elle parle aussi d'organisation, de discipline, de charge mentale, de bien-être physique et mental, et de l'importance de penser sa santé sur le long terme.Dans cet épisode, nous abordons :apprendre une langue à l'âge adultela motivation et la discipline au quotidienl'organisation quand on est parentle rapport aux écrans et aux réseaux sociauxle bien-être physique et mentalla gestion du temps et des prioritéscomment retrouver le plaisir d'apprendreUn épisode inspirant pour toutes celles et ceux qui veulent reprendre l'apprentissage d'une langue à l'âge adulte, même avec des enfants en bas âge. ✅ La NEWSLETTER:https://www.sicomprendo.net/newsletter/✅ Le KIT DE SURVIE EN VOYAGE - automatiser les 30 phrases esentielles en espagnol en voyage:https://sicomprendo.gurucan.com/plans/69ef547d64c2fd0013a33718✅​ (OFFERT) Télécharge ton CAHIER OFFERT POUR FAIRE TES PREMIERS PAS EN ESPAGNOL: https://www.sicomprendo.net/cadeaux-d... ✅​ (TRANSCRIPTIONS ET EXERCICES) L'ebook "LE CARNET COMPAGNON DU PODCAST" (transcriptions, exercices et audios pour aller plus loin):https://sicomprendo.gurucan.com/plans...✅​ (COURS D'ESPAGNOL EN LIGNE)Les programmes pour apprendre l'espagnol avec moi: https://www.sicomprendo.net/offres/✅ (MON LIVRE DE VOCABULAIRE): https://www.deboecksuperieur.com/livre/9782807364714-vocabulaire-espagnol-a1-a2-en-1000-mots-200-cartes-mentales-et-en-audio-avec✅​ (COMPTE INSTAGRAM): / paloma.sicomprendo✅​ (PAGE FACEBOOK): https://www.facebook.com/profile.php?...Ce Podcast pour Apprendre l'Espagnol s'adresse aux Débutants et Faux-débutants Francophones qui veulent Apprendre à Parler Espagnol avec une Méthode Immersive et Naturelle pour un projet d'Expatriation, pour prendre la Retraite en Espagne, Communiquer avec leur famille ou tout simplement pour le Plaisir d'Apprendre une nouvelle langue.Auteur - Compositeur de la musique du podcast: Guy Berrier

Pour suivre nos Actus du jour, RDV sur notre chaîne dédiée : ‪@hugodecrypteactus‬ Pour suivre l'actualité au fil des heures sur Instagram : / hugodecrypte ———Vidéo produite et présentée par HugoDécrypteJournalistes : Léah Boukobza, Benjamin Aleberteau, Hugo TraversCadreurs : Vanon Borget, Noé PériquetMonteurs : Manon Langlais, Anthony OchoaÉtalonnage : Vanon BorgetMotion designer : Manon LanglaisMixage : Arthaud VersaveaudMiniature : Doryan HinckerDirectrice de production : Marie DelvalléeChargé de production éditoriale : Clément ChauletChargée de production : Fiona GouzeAssistante de production : Amandine BarAdministratrice de production : Sterenn HallAssistant administratif de production : Emeric IoossDirectrice commerciale : Chloé LeveugleResponsable de partenariats : Caroline SoubevVoix partenariat : Garance ChalvinConceptrice-rédactrice partenariat : Léa SaadCoordinatrice de production : Emma SéveracCadreurs sponso : Vanon Borget, Noé PériquetIllustrateur : Tosma StudioMonteur sponso : Vanon BorgetRemerciements : Iris, Juliette, EmmaCrédits musiques : ArtlistCrédits images : Astérix & Obélix : Mission Cléopâtre, Atypical, Bad Teacher, Breaking Bad, Britney Spears - Baby One More Time, Communication Réseau d'Éducation La Salle France, Cyprien, Ducobu, Fais pas ci, fais pas ça, Friends, Gilmore Girls, Gossip Girl, Harry Potter, Heartstopper, High School Musical, INA Média Clip, La moutarde me monte au nez, Le Cercle des Poètes Disparus, Les Choristes, Les Beaux Gosses, Les Profs, LOL, Lolita malgré moi, Malcolm, Malik Bentalah - Les notes à l'école, Max PPP, Mcfly & Carlito, Mister V, Monstres et Cie, Mr Bean, Palmashow, Pokémon, Première Année, Serge le Mytho, Sex Education, SouthPark, Squeezie - L'académie des cancres, Titeuf, Vice Versa 1 et 2, Will Hunting, Young Royals, 300HD MEDIA / UNFOLD 2026 Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Apprends les bases essentielles de l'espagnol en seulement 5 minutes grâce à ce cours express spécialement conçu pour les voyageurs débutants.Dans cet épisode, tu vas découvrir des exemples de mots et expressions indispensables pour survivre en voyage en Espagne ou en Amérique latine : salutations, formules de politesse, vocabulaire utile au quotidien et phrases clés pour commander au restaurant.✅ Le KIT DE SURVIE EN VOYAGE - automatiser les 30 phrases esentielles en espagnol en voyage:https://sicomprendo.gurucan.com/plans/69ef547d64c2fd0013a33718✅​ (OFFERT) Télécharge ton CAHIER OFFERT POUR FAIRE TES PREMIERS PAS EN ESPAGNOL: https://www.sicomprendo.net/cadeaux-d... ✅​ (TRANSCRIPTIONS ET EXERCICES) L'ebook "LE CARNET COMPAGNON DU PODCAST" (transcriptions, exercices et audios pour aller plus loin):https://sicomprendo.gurucan.com/plans...✅​ (COURS D'ESPAGNOL EN LIGNE)Les programmes pour apprendre l'espagnol avec moi: https://www.sicomprendo.net/offres/✅ (MON LIVRE DE VOCABULAIRE): https://www.deboecksuperieur.com/livre/9782807364714-vocabulaire-espagnol-a1-a2-en-1000-mots-200-cartes-mentales-et-en-audio-avec✅​ (COMPTE INSTAGRAM): / paloma.sicomprendo✅​ (PAGE FACEBOOK): https://www.facebook.com/profile.php?...Ce Podcast pour Apprendre l'Espagnol s'adresse aux Débutants et Faux-débutants Francophones qui veulent Apprendre à Parler Espagnol avec une Méthode Immersive et Naturelle pour un projet d'Expatriation, pour prendre la Retraite en Espagne, Communiquer avec leur famille ou tout simplement pour le Plaisir d'Apprendre une nouvelle langue.Auteur - Compositeur de la musique du podcast: Guy Berrier

Dans cet épisode, on découvre les liens inattendus entre la France et le Mexique, depuis les conflits historiques comme la Guerre des Pâtisseries et l'intervention française au XIXe siècle, jusqu'aux échanges culturels qui continuent aujourd'hui.

Dans cet épisode spécialement conçu pour les francophones débutants et faux-débutants, révisez et testez vos connaissances des nombres en espagnol grâce à un quiz interactif et progressif.Que vous soyez au tout début de votre apprentissage ou que vous souhaitiez consolider vos bases, ce podcast vous propose plusieurs niveaux de difficulté pour apprendre à comprendre et utiliser les nombres en espagnol avec une approche ludique.- Épisode sur les nombres de 0 à 15:https://www.spreaker.com/episode/11-les-nombres-de-0-a-15-en-espagnol--42856419- Épisode sur les nombres jusqu'à 100:https://www.spreaker.com/episode/ep19-comprendre-les-nombres-en-espagnol-jusqu-a-100--42856433✅​ (OFFERT) Télécharge ton CAHIER OFFERT POUR FAIRE TES PREMIERS PAS EN ESPAGNOL: https://www.sicomprendo.net/cadeaux-d... ✅​ (TRANSCRIPTIONS ET EXERCICES) L'ebook "LE CARNET COMPAGNON DU PODCAST" (transcriptions, exercices et audios pour aller plus loin):https://sicomprendo.gurucan.com/plans...✅​ (COURS D'ESPAGNOL EN LIGNE)Les programmes pour apprendre l'espagnol avec moi: https://www.sicomprendo.net/offres/✅ (MON LIVRE DE VOCABULAIRE): https://www.deboecksuperieur.com/livre/9782807364714-vocabulaire-espagnol-a1-a2-en-1000-mots-200-cartes-mentales-et-en-audio-avec✅​ (COMPTE INSTAGRAM): / paloma.sicomprendo✅​ (PAGE FACEBOOK): https://www.facebook.com/profile.php?...Ce Podcast pour Apprendre l'Espagnol s'adresse aux Débutants et Faux-débutants Francophones qui veulent Apprendre à Parler Espagnol avec une Méthode Immersive et Naturelle pour un projet d'Expatriation, pour prendre la Retraite en Espagne, Communiquer avec leur famille ou tout simplement pour le Plaisir d'Apprendre une nouvelle langue.Auteur - Compositeur de la musique du podcast: Guy Berrier

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/responding-to-the-science-biologics-in-practice-in-copd-10511SummaryThis enduring podcast activity provides pulmonologists and clinicians managing COPD with timely updates on the evolving role of biologics management. Featuring expert discussions, the program explores recent GOLD guideline revisions, the integration of new and emerging biologic therapies, and evidence-based decision-making based on clinical trial data and real-world practice.Covering guidelines, clinical trials, and clinical scenario, this activity emphasizes the translation of complex data into practical strategies. Learners will gain improved knowledge and competence related to patient selection, eosinophil thresholds, and clinical decision making.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesDiscuss recent evidence surrounding the use of biologic agents in the management of patients with COPD, including patient populations and outcomesIntegrate the use of biologic agents into the management of patients with COPD based on guidelines and clinical evidence for new and emerging agentsThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here. Disclosure of Commercial SupportThis educational activity is supported by an independent medical education grant from GSK and an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/personalized-antidepressant-choices-for-better-outcomes-in-mdd-10266SummaryEmphasizing a measurement-based, patient-centered model, this is an enduring podcast/webcast designed for psychiatrists who seek to refine their approach to managing major depressive disorder (MDD). Despite an expanding array of pharmacologic options, many patients continue to experience side effects and residual symptoms that undermine adherence and long-term recovery. Led by Drs. Gregory Mattingly and Gerald Maguire, this activity equips clinicians with evidence-based strategies to compare the nuanced risk–benefit profiles of antidepressants and apply them to individualized treatment plans.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAssess the risk–benefit profiles of available antidepressants, including their impact on residual symptoms, to optimize treatment decisions for patients with MDDImplement personalized, measurement-based treatment strategies for patients with MDD to address residual symptoms, promote adherence, and improve outcomesThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.75 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/adhd-sleep-and-symptom-control-10355SummaryEarly-morning symptom control remains a critical gap in ADHD management, often contributing to family stress and impaired daily functioning. In this podcast/webcast activity, Dr. Joel Young and Jo Hughes, DMSc, PA-C, CAQ-PSY, explore the limitations of traditional ADHD medications in achieving full-day coverage and discuss available strategies to improve early-morning outcomes. Learners will gain practical insights into the clinical use of nighttime-dosed medications, including an innovative delayed-release/extended-release stimulant, and understand the pharmacologic characteristics that contribute to its efficacy in providing sustained symptom control.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveExamine the ADHD treatment options that use nighttime dosing to achieve full-day symptom controlThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Collegium Pharmaceutical, Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Rosalia a sorti son quatrième album LUX début novembre 2025 et tout le monde en parle. Mais, que vaut-il vraiment?Dans cet épisode je te raconte mon avis sincère sur le dernier album de Rosalía dans un espagnol clair et compréhensible pour t'aider à apprendre l'espagnol de façon naturelle avec la musique de Rosalía.Bonne écoute !

Réserve ta place pour 2026 ici:

Ce n'est pas la peine d'utiliser le code BLACKFRIDAY2025, il ne fonctionnera pas...

Stropkov, Svidník, Revúca, Rožňava ale aj Skalica či Púchov. Aj to sú oblasti, kde odborníci z Protimonopolného úradu odhalili vyššiu koncentráciu na trhu práce. Keď je konkurencia slabá a zamestnávateľov málo, trpi aj zamestnanci.Situácia sa síce zlepšuje, no stále nie sme pomerom miezd k výkonu ekonomiky ani na európskom priemere, hovorí hlavný ekonóm úradu Vladimír Peciar.

Aujourd'hui c'est le tour d'une nouvelle histoire inspirante d'un élève de "Sí comprendo": Yannick.Il a suivi le programme "Espagnol pour voyager", puis "Hola caracola" jusqu'à consolider son niveau B1, et il a enchaîne sur "Café fragnol" pour continuer à s'améliorer dans un cadre motivant et stimulant.Le challenge DÉBLOQUE TON ORAL EN ESPAGNOL, édition novembre 2025: https://www.sicomprendo.net/challenge...Bonne écoute !

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/personalizing-adhd-management-using-methylphenidate-10448SummaryEffective ADHD management demands more than symptom control—it requires personalized treatment strategies aligned with the patient's unique daily functional needs. Through clinical case examples and pharmacologic comparisons, learners will explore how tailoring treatment using immediate-release (IR), extended-release (ER), and delayed-release/extended-release (DR/ER) methylphenidate (MPH) formulations can optimize symptom control aligned with patients' daily routines and responsibilities. In this podcast/webcast activity, Joel Young, MD, and Jo Hughes, DMSc, PA-C, CAQ-PSY will highlight practical strategies for implementing personalized ADHD treatment plans, with a focus on the unique benefits of evening-dosed DR/ER-MPH in addressing early-morning and evening functional impairments.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesEvaluate the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of ER-, DR/ER-, and IR-MPH formulations to implement safe, effective, and personalized ADHD treatment decisions.Discuss individualization of ADHD treatment plans by selecting MPH formulations based on PK profiles, patient characteristics, and functional goals to optimize symptom control and adherence.This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Collegium Pharmaceutical, Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

La période d'Halloween, de la Toussaint et de la Fête des morts vient de se terminer… mais les frissons ne sont pas finis !

Aujourd'hui tout le monde te parle sur internet de comment "réussir tes objectifs" en espagnol.Mais comment les définir de façon concrète? Et surtout, comment les atteindre?Dans l'épisode de la semaine je partage avec toi un extrait de la session de coaching linguistique que j'ai animée dernièrement avec mes élèves. Tu vas comprendre quels sont les pièges à éviter pour que tes objectifs ne se transforment pas en "telenovela" et garder la motivation.

Je t'offre le premier épisode de l'atelier sonore privé MINI-SPRINT DE VOCABULAIRE: comprendre le fonctionnement de ta mémoire pour retenir 2 fois plus de mots en espagnol.C'est l'échauffement idéal du programme SPRINT DE VOCABULAIRE, qui te permettra de parcourir mon livre "Vocabulaire espagnol A1-A2 en 1000 mots" de A à Z en seulement 10 semaines.Dernière chance pour s'y inscrire en 2025!

Découvrons ensemble le vocabulaire des matières scolaires grâce à une petite histoire compréhensible adaptée aux niveaux débutants.Apprends des structures utiles pour parler de tes préférences à l'école.Accès au MINI-SPRINT:https://www.sicomprendo.net/mini-sprint-de-vocabulaire/La newsletter.

Découvre les coulisses derrière la création de mon premier livre "Vocabulaire espagnol A1-A2 en 1000 mots: 200 cartes mentales et en audio " (De Boeck Supérieur, 2025).J'ai interviewé mon éditrice (Marie-Amélie Eglebienne) afin de partager avec vous le processus de création du livre.Comment est né le concept?Comment se passe la création d'un livre de A à Z?Quels sont les points forts de ce livre?Rejoins le SPRINT DE VOCABULAIRE, on démarre le 29 septembre 2025!https://www.sicomprendo.net/sprintvocabulaire/Si tu as zappé cette période d'inscription, abonne-toi à la newsletter pour que je te prévienne de façon prioritaire de l'ouverture des inscriptions de la nouvelle édition du SPRINT DE VOCABULAIRE.La newsletter.

Bienvenue dans la mini-série estivale sur comment mémoriser le vocabulaire en espagnol efficacement pour arrêter de chercher ses mots.Dans ce cinquième et dernier épisode je te présente ma toute nouvelle formation SPRINT DE VOCABULAIRE que j'ai créé autour de mon premier livre "Vocabulaire espagnol A1-A2 en 1000 mots: 200 cartes mentales et en audio " (De Boeck Supérieur, 2025).Profite de l'OFFRE ÉCLAIR avant le lundi 18 août.Si tu as zappé cette période d'inscription, abonne-toi à la newsletter pour que je te prévienne de façon prioritaire de l'ouverture des inscriptions de la nouvelle édition du SPRINT DE VOCABULAIRE.La newsletter.

Bienvenue dans la mini-série estivale sur comment mémoriser le vocabulaire en espagnol efficacement pour arrêter de chercher ses mots.Dans ce quatrième épisode je te présente mon premier livre "Vocabulaire espagnol A1-A2 en 1000 mots: 200 cartes mentales et en audio " (De Boeck Supérieur, 2025).Pour le commander sur le site de la maison d'édition c'est ici.Pour le commander sur Amazon.Bonne écoute! Et pense à le partager s'il t'a paru utile!

Bienvenue dans la mini-série estivale sur comment mémoriser le vocabulaire en espagnol efficacement pour arrêter de chercher ses mots.Dans ce troisième épisode tu vas auto-évaluer ton niveau d'espagnol grâce à 5 défis de vocabulaire. Chaque capsule comprend un conseil pratique et un défi facile à mettre en place rapidement.Bonne écoute! Et pense à le partager s'il t'a paru utile!

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/targeting-cause-emerging-therapies-menopausal-vms-10267SummaryThis enduring podcast activity explores groundbreaking advancements in the treatment of menopausal vasomotor symptoms (VMS), emphasizing non-hormonal therapies. Dr. Andrea Singer and Dr. Genevieve Neal-Perry discuss the underlying biology of menopause, particularly the role of neurokinin (NK) receptors, and introduces the science behind new therapeutic agents, as well as their clinical trial data.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveDiscuss the clinical trial data for new and emerging non-hormonal therapiesThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported in part by an educational grant from Bayer HealthCare Pharmaceuticals Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/personalizing-care-identifying-the-right-patients-for-new-treatments-10268SummaryDr. Genevieve Neal-Perry and Dr. Andrea Singer focus on practical strategies in the personalized management of menopausal vasomotor symptoms (VMS). The discussion covers the importance of routine and individualized screening for VMS, with attention to healthcare disparities and the diverse ways menopause is discussed and experienced across populations, before covering patient selection criteria for newer non-hormonal treatments.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesIntegrate routine and individualized screening methods to identify patients with menopausal VMS, with attention to healthcare disparitiesIntegrate new and emerging agents into the treatment of women with menopausal VMS, based on patient characteristics and preferenceThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported in part by an educational grant from Bayer HealthCare Pharmaceuticals Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Bienvenue dans la mini-série estivale sur comment mémoriser le vocabulaire en espagnol efficacement pour arrêter de chercher ses mots.Dans ce deuxième épisode épisode tu vas découvrir la clé pour passer de "je cherche trop mes mots en espagnol" à "je suis capable de faire des phrases sans réfléchir".Chaque capsule comprend un conseil pratique et un défi facile à mettre en place rapidement.Bonne écoute! Et pense à le partager s'il t'a paru utile!

Bienvenue dans la mini-série estivale sur comment mémoriser le vocabulaire en espagnol efficacement pour arrêter de chercher ses mots.Dans ce premier épisode tu vas découvrir la clé pour éviter les trous de mémoire quand tu parles espagnol. Si tu as l'impression de connaître le vocabulaire, mais de rester bloqué au moment de faire des phrases, c'est épisode est fait pour toi.Chaque capsule comprend un conseil pratique et un défi facile à mettre en place rapidement.Bonne écoute! Et pense à le partager s'il t'a paru utile!

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:http://mycme.com/courses/the-cognitive-side-of-major-depressive-disorder-10221SummaryDespite significant improvements in mood symptoms, many patients with MDD continue to experience persistent residual symptoms—particularly cognitive impairments—that hinder full functional recovery. In this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Roger McIntyre discuss the often-overlooked role of cognitive dysfunction in MDD recovery, highlighting how these impairments correlate strongly with reduced workplace productivity, social withdrawal, and elevated relapse risk, ultimately impeding long-term outcomes. Their conversation provides listeners with an in-depth understanding of the presentation of cognitive impairment and residual symptoms in MDD, as well as strategies to foster resilience, enhance patient engagement, and promote functional recovery.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Recognize the clinical significance of residual symptoms in MDD, with a focus on cognitive impairment, and their impact on patient functioning and treatment outcomesThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.25 hours of pharmacology).Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/strategies-and-real-world-impact-of-the-stimulant-crisis-10220SummaryThe stimulant medication shortage has introduced new challenges in managing ADHD, affecting both patients' access to essential treatments and clinicians' ability to provide consistent care. In this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Roger McIntyre explore the impact of these shortages, particularly on cognitive functioning, treatment continuity, and daily life for individuals with ADHD. Their discussion also examines stimulant misuse and diversion, looking at trends in medication sourcing, formulations most susceptible to abuse, and strategies to reduce the risk of misuse. By the end of the episode, learners will be equipped with timely insights and real-world tools to optimize ADHD management amid evolving supply and safety challenges.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the impact of stimulant shortages on individuals with ADHDIncorporate best-practice clinical strategies to minimize the risk of stimulant misuse in the treatment of ADHDThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is not supported by an educational grant.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/the-latest-data-in-ckd-progression-10197SummaryEmerging evidence highlights the potential of GLP-1 receptor agonists (GLP-1 RAs) to slow CKD progression and reduce cardiovascular and kidney-related mortality in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). Yet, despite updated guidelines, these therapies remain underused. This program will explore the latest clinical data supporting the role of GLP-1 RAs in risk mitigation and provide practical strategies for implementing guideline-based treatment to reduce cardio-renal risk and improve outcomes in patients with T2D and CKD.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Discuss emerging data on GLP-1 RA therapy for CKD progression in T2DImplement guideline-based care to minimize CV risk and CKD progressionThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an educational grant from Novo Nordisk.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Je te propose un extrait du "CHALLENGE: débloquer ton espagnol pour oser parler avec les natifs sans stress" qui vient de se terminer.C'est un extrait du 4e LIVE dans lequel je partageais les 6 piliers à maîtriser pour passer de débutant à intermédiaire en espagnol, ainsi que le plan d'action à suivre.Pour recevoir le REPLAY, abonne-toi à la newsletter ici.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/answers-in-chronic-spontaneous-urticaria-10190SummaryIn this short CE/CME activity, moderator Dr. Brad Glick works with dermatology expert Dr. Gil Yosipovitch to answer your top questions regarding chronic spontaneous urticaria, as gathered from the 2025 NACE Conversations in Dermatology symposium. Questions cover diagnosis, treatment individualization, and more!Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Assess the disease burden and impact on QoL in patients with CSUEvaluate current and emerging therapies for CSUThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an independent educational grant from Sanofi and Regeneron Pharmaceuticals.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Pour retrouver l'ouvrage du Pr Philip https://www.albin-michel.fr/antideprime-9782226494207______Vidéo produite par HugoDecrypteEntretien écrit et mené par Hugo TraversAvec la participation du Pr Pierre PhilipJournalistes : Samy Rabbata Hugo TraversDirectrice de production : Marie DelvalléeChargé de production : Clément ChauletAssistants de production : Noé Périquet, Amandine BarCadreurs : Vanon Borget, Benjamin CarrionIngénieure du son : Inês Dos SantosMaquilleuse : Kim DesnoyersMonteuse : Manon LanglaisÉtalonnage : Toutes voiles dehors - Hugues DardartMiniature : Oncle SidMixage : Florent SimonHD MEDIA / UNFOLD PRODUCTION 2025 Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Beaucoup de francophones rêvent d'avoir un jour une résidence secondaire en Espagne, soit parce qu'ils voyagent régulièrement dans le pays, soit pour préparer leur retraite au soleil.Dans cet interview, Bernadette (élève de mon école d'espagnol en ligne depuis 2023) nous raconte son processus d'achat de résidence secondaire en Espagne et comment ce projet a motivé son désir de se mettre sérieusement à l'espagnol.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/copd-inflammation-exacerbations-your-questions-answered-10143SummaryRejoin the conversation on COPD, inflammation, and new and emerging agents as two of our expert faculty come together to answer your top questions. Questions submitted from the recent Conversations in Primary Care live virtual symposia guide the discussion as we dig a bit deeper on type 2 inflammation, changes in COPD management, and new and emerging agents – including recently approved biologic agents – for COPD.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Review the relationship between inflammation, exacerbation, and disease progression in COPD, noting different inflammatory endotypes of patients with COPDDiscuss recent evidence surrounding the use of biologic agents in the management of patients with COPD and type 2 inflammationIntegrate current guidelines with clinical data on new and emerging agents for the management of COPD, distinguishing patients with and without markers of type 2 inflammationThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Le 28 avril 2025 une panne électrique à échelle nationale s'est produite en Espagne et au Portugal. Comment les Espagnols ont-ils vécu cet évènement?Pratique la compréhension orale en espagnol et apprends la conjugaison et le vocabulaire de façon naturelle avec une nouvelle histoire facile et d'actualité.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/psychiatric-therapeutics-in-a-digital-world-10096SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding delve into the digital world and breakdown its effects on mental health—both positive and negative. By the end of the episode, learners will have a better understanding of the relationship between screen time, social media, and attention, including clinical pearls for how to harness prescription technology to enhance patient outcomes in ADHD and depression.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Examine the relationship between social media and attentionIncorporate FDA-authorized digital therapeutics into ADHD and depression management plans based on current clinical evidenceThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/clinical-updates-in-schizophrenia-10097SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding go through the evolving landscape of schizophrenia treatments. Listen as they discuss the pros and cons of various second-generation antipsychotics, the science behind muscarinic modulation for psychosis, and recent updates in clozapine prescribing. At the end of the session, the doctors answer several audience questions to enhance your understanding of these developments and how they apply to clinical practice.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Integrate recent clinical data on antipsychotic treatments and relapse prevention strategies into management plans for patients with schizophreniaDescribe the role of muscarinic modulation in psychosisThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.75 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Bienvenue dans la nouvelle série d'épisodes spécial "interview aux anciens membres de Sí comprendo".Aujourd'hui j'ai la chance d'avoir un de mes meilleurs élèves. Il partage son parcours de débutant absolu en espagnol à intermédiaire. Il a commencé avec des méthodes autodidactes, jusqu'à ce qu'il a compris qu'il avait besoin d'être accompagné pour aller plus loin.

Découvrez ma formation en ligne sur les fondamentaux de l'accueil !Chers Insiders, Notre voyage dans l'expérience et l'excellence de service continue et je me réjouis de rencontrer des invités toujours plus passionnants. Ce Podcast n'en est encore qu'à son commencement, mais les retours que vous me partagez m'encouragent à continuer ce beau projet. Si vous souhaitez que j'aille à la rencontre de personnalités remarquables, dites-le moi sur mes différents réseaux et partons ensemble à leur rencontre. Je suis Maxime Blot, artisan hôtelier, et vous êtes sur Hospitality Insiders. Mon invité du jour est un expert du Marketing et de la communication, quoi de mieux pour compléter notre vision de l'expérience client ? Il a également une longue carrière dans l'entrepreneuriat et je peux dire sans me tromper que le développement durable est une valeur forte que nous partageons. Je suis heureux de l'accueillir et je me languis d'en savoir plus sur son parcours, bonjour Olivier Dufit. Notes et références : La coopérative The Originals, Human Hotels & Resorts Travelclick, fournisseur mondial de solutions pour les hôteliers OTA : Online Travel Agency GDS : Global Distribution System LMS : Learning Management System RSE : Responsabilité Sociétale des Entreprises PMS : Property Management System Livre : les quatre accords toltèques de Don Miguel Ruiz Linkedin : Olivier Dufit Email : olivier_dufit@yahoo.frSi cet épisode vous a passionné, rejoignez-moi sur :L'Hebdo d'Hospitality Insiders, pour ne rien raterL'Académie Hospitality Insiders, pour vous former aux fondamentaux de l'accueilLinkedin, pour poursuivre la discussionInstagram, pour découvrir les coulissesLa bibliothèque des invités du podcastMerci de votre fidélité et à bientôt !Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/characterizing-connected-conditions-in-psychiatry-10045SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding discuss some of the complexities of mental health care: overlapping symptoms and differential diagnoses. Listeners will learn about the connections between certain psychiatric disorders and how symptom combinations may influence treatment and patient outcomes. The program will also review strategies to help with accurate diagnoses in complex patient presentations, teaching listeners how to take a thorough patient history and use that information to guide treatment decisions.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the impact of comorbid mental health diagnoses on patient outcomesEmploy strategies to aid in the differential diagnosis of patients who present with symptoms suggestive of multiple mental health conditionsThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/practical-management-for-complex-psychiatric-cases-10046SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding teach by case example. Listeners will hear an introduction to a complex patient presentation and then be taken through expert strategies to discern the correct diagnoses. The program will conclude with the same case example to tie together the education and demonstrate these strategies in practice.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Apply evidence-based strategies to develop personalized treatment plans when managing patients with comorbid mental health disordersThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

✨ Rien n'est impossible à ceux qui rêvent assez grand. À vos rêves. ✨Aujourd'hui, je suis un petit peu émue de me relancer dans des épisodes solo. Après 7 ans de podcast, c'est un vrai retour aux sources. Les temps ont changé. Je change, j'évolue. Et j'ai envie de retrouver cet espace où je peux partager avec vous, sans filtre.Quand j'ai lancé ce podcast, j'étais concentrée à 400% sur Gemmyo. Mais j'avais besoin de me lancer dans autre chose que ma vie professionnelle. Ce podcast m'a complètement allégée à l'époque. Il m'a permis de prendre du recul, de réfléchir autrement.Les interviews ne disparaissent pas, loin de là mais j'ai aussi envie de vous parler directement, de vous emmener avec moi dans mes réflexions.Dans cet épisode, je partage avec vous 2 habitudes qui ont profondément changé ma manière de vivre et de travailler. Rien d'extravagant vous allez me dire, mais des ajustements simples qui ont eu un impact immense au fil du temps.Dites-moi si ce format vous plaît, si vous souhaitez m'entendre plus souvent en solo. Ce podcast existe grâce à vous, et vos retours sont précieux.Bonne écoute !

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/management-approaches-for-eoe-9991SummaryThe American College of Gastroenterology has published the first new guidelines for the treatment of eosinophilic esophagitis (EoE) since 2013. In this CME/CE podcast, Drs. Paul Feuerstadt and Brooks Cash discuss these latest recommendations, reviewing the role of proton pump inhibitors, topical steroids, diet elimination, a biologic, and esophageal dilation in the management of this increasingly recognized condition.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Assess the efficacy and safety profile of approved agents for EoE, with a focus on swallowed corticosteroids, in the management of EoEApply evidence-based guidelines to optimize treatment outcomes and improve the quality of life for patients with EoEThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/on-the-lookout-for-eoe-9990SummaryIn this CME/CE podcast, two gastroenterologists discuss the increasing prevalence of eosinophilic esophagitis (EoE), our evolving understanding of its pathophysiology, and its varied clinical presentation. Drs. Brooks Cash and Paul Feuerstadt also review the need for early identification of the condition, and discuss the latest American College of Gastroenterology guideline for diagnosis.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Identify common clinical presentations and diagnostic challenges to facilitate early diagnosis of EoE in diverse patient populationsThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/exercise-for-mental-health-9983SummaryWe've heard it time and time again, exercise is of great importance to our physical health—but did you know it is also important to our mental health? An activity as simple as taking a daily walk can have a substantial positive impact on depression outcomes. Despite the widespread benefits of exercise, patients and providers may overlook its importance in treatment plans. This presentation focuses on the mental and physical benefits of exercise, drawing insights from published data and clinical experience.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Gerald Maguire discuss the benefits of exercise on both physical and mental health. Throughout the episode, they go through the research that supports the benefits of exercise, as well as provide practical strategies to encourage your patients to adopt exercise into their lifestyles.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the impact of exercise on mental healthReview data from prospective studies investigating the relationship between exercise and depressionThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/psychedelics-for-depression-9984SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Gerald Maguire explore the emerging role of psychedelics in treating mental health conditions. Listeners will learn about the mechanisms of action of psychedelic therapeutics and gain insights into their effects on the brain and behavior. The program will also review recent clinical trial data on the efficacy of psychedelic treatments for major depressive disorder (MDD), as well as provide expert insights on how to discuss the future of psychedelics with patients.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the mechanism of action of psychedelic therapeuticsReview clinical trial data regarding the use of psychedelic treatments in MDDThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.75 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.